Rosa Maria Marfisi
Overview
Explore the profile of Rosa Maria Marfisi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
1827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rambaldi A, Grassi A, Masciulli A, Boschini C, Mico M, Busca A, et al.
Lancet Oncol
. 2015 Oct;
16(15):1525-1536.
PMID: 26429297
Background: The standard busulfan-cyclophosphamide myeloablative conditioning regimen is associated with substantial non-relapse mortality in patients older than 40 years with acute myeloid leukaemia who are undergoing allogeneic stem-cell transplantation. Because...
2.
Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi R, Cosmi D, et al.
Circ Heart Fail
. 2015 May;
8(3):428-37.
PMID: 25925415
Background: Moderate, regular alcohol consumption is generally associated with a lower risk of cardiovascular events but data in patients with chronic heart failure are scarce. We evaluated the relations between...
3.
Bassan R, Masciulli A, Intermesoli T, Audisio E, Rossi G, Pogliani E, et al.
Haematologica
. 2015 Mar;
100(6):786-93.
PMID: 25749825
Developing optimal radiation-free central nervous system prophylaxis is a desirable goal in acute lymphoblastic leukemia, to avoid the long-term toxicity associated with cranial irradiation. In a randomized, phase II trial...
4.
Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, et al.
Am Heart J
. 2013 Jan;
165(2):208-15.e4.
PMID: 23351824
Unlabelled: Treatment with long-chain n-3 polyunsaturated fatty acids (n-3 PUFAs) can improve clinical outcomes in patients with heart failure (HF). Circulating levels of n-3 PUFA, an objective estimation of exposure,...
5.
Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, et al.
N Engl J Med
. 2012 Dec;
368(1):22-33.
PMID: 23216616
Background: Current treatment recommendations for patients with polycythemia vera call for maintaining a hematocrit of less than 45%, but this therapeutic strategy has not been tested in a randomized clinical...
6.
Levantesi G, Marfisi R, Franzosi M, Maggioni A, Nicolosi G, Schweiger C, et al.
Int J Cardiol
. 2012 Jan;
167(1):262-9.
PMID: 22261690
Background: To date uric acid (UA) is not considered a cardiovascular risk factor, although evidence about a relationship between UA and cardiovascular diseases has been reported. Methods: Information from 10,840...
7.
Sattar N, Preiss D, Murray H, Welsh P, Buckley B, de Craen A, et al.
Lancet
. 2010 Feb;
375(9716):735-42.
PMID: 20167359
Background: Trials of statin therapy have had conflicting findings on the risk of development of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of published...
8.
Marchioli R, Marfisi R, Borrelli G, Chieffo C, Franzosi M, Levantesi G, et al.
J Cardiovasc Med (Hagerstown)
. 2007 Oct;
8 Suppl 1:S34-7.
PMID: 17876196
The GISSI-Prevenzione trial established the efficacy of n-3 polyunsaturated fatty acids (PUFAs) for reducing mortality in patients after recent myocardial infarction. The generalisability of such results to clinical practice could...
9.
Galli M, Borrelli G, Jacobsen E, Marfisi R, Finazzi G, Marchioli R, et al.
Blood
. 2007 Apr;
110(4):1178-83.
PMID: 17440049
To assess the clinical significance of lupus anticoagulants (LAs) and antiphospholipid antibodies (aPLs) toward thrombosis and abortions, we measured them in 112 patients whose samples were available at enrollment in...
10.
Vannucchi A, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, et al.
Blood
. 2007 Mar;
110(3):840-6.
PMID: 17379742
JAK2 617V>F mutation occurs in a homozygous state in 25% to 30% of patients with polycythemia vera (PV) and 2% to 4% with essential thrombocythemia (ET). Whether homozygosity associates with...